Compare · BEN vs HTGC
BEN vs HTGC
Side-by-side comparison of Franklin Resources Inc. (BEN) and Hercules Capital Inc. (HTGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BEN and HTGC operate in Investment Managers (Finance), so they compete in similar markets.
- BEN is the larger of the two at $16.28B, about 5.7x HTGC ($2.86B).
- Over the past year, BEN is up 43.5% and HTGC is down 15.7% - BEN leads by 59.3 points.
- BEN has been more active in the news (10 items in the past 4 weeks vs 2 for HTGC).
- BEN has more recent analyst coverage (24 ratings vs 13 for HTGC).
Franklin Resources Inc.
Franklin Resources, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, institutions, pension plans, trusts, and partnerships. It launches equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. The firm invests in the public equity, fixed income, and alternative markets. Franklin Resources, Inc. was founded in 1947 and is based in San Mateo, California with an additional office in Hyderabad, India.
Hercules Capital Inc.
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in Decembe
Latest BEN
- Franklin Resources Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Franklin Templeton Launches YCLO, an Actively Managed Investment Grade CLO ETF
- Fiduciary Trust International Welcomes Harrison Laing as New York-Based Wealth Director
- Franklin Resources, Inc. Announces Preliminary Month-End Assets Under Management
- Amendment: SEC Form 40-6B/A filed by Franklin Resources Inc.
- Franklin Templeton and MoonPay Partner to Expand Institutional Access to Tokenized Money Market Funds
- Franklin Templeton Canada Announces ETF Cash Distributions
- Franklin Resources, Inc. Announces Quarterly Dividend
- Franklin Templeton Canada Announces Final Valuations for Terminated ETF Series
- Clarion Partners Executes $1 Billion in Strategic Healthcare Real Estate Transactions Across Multiple High-Growth Markets
Latest HTGC
- Perk Secures $300 Million Credit Facility to Accelerate Global Growth of Its AI-Native Platform
- New insider Olson Andrew claimed ownership of 30,386 shares (SEC Form 3)
- Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders
- Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
- SEC Form 10-Q filed by Hercules Capital Inc.
- Hercules Capital Reports First Quarter 2026 Financial Results
- SEC Form DEFA14A filed by Hercules Capital Inc.
- Hercules Capital Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital
- Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million